“Outcome of Combined Temozolomide CCNU Versus Temozolomide (Standard or Extended) For Patients With Methylated MGMT Glioblastoma”. 2026. Journal of Cancer Research Updates 15 (3): 197-205. https://doi.org/10.30683/1929-2279.2026.15.18.